Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study

BACKGROUND: Several clinical trials reported that clopidogrel was superior to aspirin in secondary stroke prevention by reducing the risk of major adverse cardiovascular events (MACE). We aimed to compare the efficacy of clopidogrel with aspirin in reducing one-year risk of MACE based on real-world...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:PLoS One
Main Authors: Vidyanti, Amelia Nur, Chan, Lung, Lin, Cheng-Li, Muo, Chih-Hsin, Hsu, Chung Y., Chen, You-Chia, Wu, Dean, Hu, Chaur-Jong
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2019
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6715172/
https://ncbi.nlm.nih.gov/pubmed/31465467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0221750
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki